⌘K

Login Start Free

Home/Filings/4/0000899243-19-002869

4//SEC Filing

GARDNER JASON 4

Accession 0000899243-19-002869

CIK 0001690585other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:18 PM ET

Size

5.4 KB

Accession

0000899243-19-002869

Insider Transaction Report

Form 4

Period: 2019-02-05

Magenta Therapeutics, Inc.MGTA

DirectorSee Remarks

Transactions

Award
Stock Option (Right to Buy)
2019-02-05+182,900→ 182,900 total
Exercise: $7.13Exp: 2029-02-04→ Common Stock (182,900 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in 12 equal quarterly installments beginning on January 1, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1

filerCIK 0001741286

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 4:18 PM ET
Size: 5.4 KB

View on SEC.gov